Promethera Biosciences Competitors and Similar CompaniesClear all
Poxel's competitors and similar companies include Novartis and Genfit.
 Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2009 | Founding Date 1996 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 6 | Employees 75,883 | Employees 180 |
Valuation ($) | Valuation ($) 18.3 m | Valuation ($) N/A | Valuation ($) 280.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods €2.8m (FY, 2024) | Cost of goods $8.4b (FY, 2025) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit €3.8m (FY, 2024) | Gross profit $49.8b (FY, 2025) | Gross profit €70.8m (FY, 2025) |
Net income | Net income (€18.3m) (FY, 2024) | Net income $14b (FY, 2025) | Net income (€86m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 33.8m | Total funding raised $ 6.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyGenfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company